Cocrystal Pharma Inc. (NASDAQ: COCP)
$2.28
+0.0400 ( +1.79% ) 10.3K
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
Market Data
Open
$2.28
Previous close
$2.24
Volume
10.3K
Market cap
$23.09M
Day range
$2.25 - $2.38
52 week range
$1.33 - $3.29
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Mar 19, 2024 |
8-k | 8K-related | 14 | Mar 01, 2024 |
8-k | 8K-related | 35 | Jan 08, 2024 |
8-k | 8K-related | 14 | Jan 04, 2024 |
8-k | 8K-related | 12 | Dec 21, 2023 |
8-k | 8K-related | 14 | Dec 06, 2023 |
8-k | 8K-related | 44 | Dec 04, 2023 |
8-k | 8K-related | 33 | Nov 29, 2023 |
10-q | Quarterly Reports | 56 | Nov 13, 2023 |
8-k | 8K-related | 14 | Nov 13, 2023 |